HBSP (USA)
-
NEC: A New R&D Site in Princeton (Spanish Version)
Kuemmerle, Walter; Kobayashi, KiichiroCase HBS-803S03Service and Operations ManagementEn 1992, Daizburo Shinoda, un alto director de I + D en el NEC, tiene que lidiar con un tema de la sucesión con respecto a la dirección del sitio de I + D de NEC en Princeton, Nueva Jersey en decidir a quién nombrar como el próximo líder del NEC D sitio extranjero más importante de investigación y, Shinoda tiene a considerar una serie de factores: la estrategia global de la empresa de NEC, la historia del sitio de Princeton, y las limitaciones de...Starting at €8.20
-
Hitachi Rail Limited (B)
Collis, David J.; Kanno, Akiko; Sato, NobuoCase HBS-721365-EStrategyDescribes the strategy and organisation changes made by British executive, Alistair Domer, after he is made head of Hitachi Rail's global business. The company acquires an Italian company, continues to win contracts in the UK, but struggles to bring its gStarting at €5.74
-
Takeda Pharmaceutical Company Limited (B)
Collis, David J.; Sato, Nobuo; Kanno, AkikoCase HBS-721374-EStrategyThis case is a follow up to HBS Case No. 721-373, Takeda Pharmaceutical Company Limited (A). Following the events of the previous case, Takeda reached an agreement to acquire Ireland-based Shire Plc. The case follows some of the achievements and challengeStarting at €5.74
-
Hitachi Rail Limited (A)
Collis, David J.; Kanno, Akiko; Sato, NobuoCase HBS-721364-EStrategyHitachi must decide whether to make a British executive, who has successfully built its European rail business from scratch, head of its global rail division even though the bulk of revenues for the unit still come from Japan. The case describes, the histStarting at €8.20
-
Takeda Pharmaceutical Company Limited (A)
Collis, David J.; Sato, Nobuo; Kanno, AkikoCase HBS-721373-EStrategyThis case follows Christophe Weber, President and CEO of Takeda Pharmaceutical Company Limited, a leading pharmaceutical company headquartered in Tokyo, Japan, as Takeda considers acquiring Shire Plc, a biotech company based in Ireland. The acquisition woStarting at €8.20